89 related articles for article (PubMed ID: 23641420)
1. ProThera Biologics, Inc.: a novel immunomodulator and biomarker for life-threatening diseases.
Lim YP
R I Med J (2013); 2013 Feb; 96(2):16-8. PubMed ID: 23641420
[TBL] [Abstract][Full Text] [Related]
2. National Institutes of Health Funding in Rhode Island.
Mao G; Ramratnam B
R I Med J (2013); 2017 Jul; 100(7):22-26. PubMed ID: 28686236
[TBL] [Abstract][Full Text] [Related]
3. Inter-α inhibitor proteins: a novel therapeutic strategy for experimental anthrax infection.
Opal SM; Lim YP; Cristofaro P; Artenstein AW; Kessimian N; Delsesto D; Parejo N; Palardy JE; Siryaporn E
Shock; 2011 Jan; 35(1):42-4. PubMed ID: 20523269
[TBL] [Abstract][Full Text] [Related]
4. Showcasing bioscience in Rhode Island.
Spero D
R I Med J (2013); 2013 Feb; 96(2):15. PubMed ID: 23641419
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Research Landscape in Rhode Island.
Mao G; Ramratnam B
R I Med J (2013); 2017 Jan; 100(1):42-46. PubMed ID: 28060965
[TBL] [Abstract][Full Text] [Related]
6. Bioterrorism. Researchers question obsession with Cipro.
Enserink M
Science; 2001 Oct; 294(5543):759-61. PubMed ID: 11679638
[No Abstract] [Full Text] [Related]
7. Inter-alpha inhibitor proteins in infants and decreased levels in neonatal sepsis.
Baek YW; Brokat S; Padbury JF; Pinar H; Hixson DC; Lim YP
J Pediatr; 2003 Jul; 143(1):11-5. PubMed ID: 12915817
[TBL] [Abstract][Full Text] [Related]
8. Anthrax attack in the USA.
McCarthy M
Lancet Infect Dis; 2001 Dec; 1(5):288-9. PubMed ID: 11871791
[No Abstract] [Full Text] [Related]
9. National Institutes of Health phase I, Small Business Innovation Research applications: fiscal year 1983 results.
Vener KJ
Fed Proc; 1985 Aug; 44(11):2679-84. PubMed ID: 4018273
[TBL] [Abstract][Full Text] [Related]
10. National Institutes of Health grant awards for pain, nausea, and dyspnea research: an assessment of funding patterns in 2003.
Bradshaw DH; Nakamura Y; Chapman CR
J Pain; 2005 May; 6(5):277-93. PubMed ID: 15890630
[TBL] [Abstract][Full Text] [Related]
11. Building better biotherapeutics and vaccines by design: EpiVax, Inc., an immunology company.
Moise L; De Groot A; Marcello A; Tassone R; Martin W; Cousens L
R I Med J (2013); 2013 Feb; 96(2):19-21. PubMed ID: 23641421
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial therapy for anthrax.
Torres-Tortosa M; Caballero-Granado FJ; Moreno I; Canueto J
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):696; author reply 697. PubMed ID: 12373508
[No Abstract] [Full Text] [Related]
13. Zoonotic diseases in India: focus on research options for anthrax control.
Chogle AR
J Assoc Physicians India; 2012 Feb; 60():87. PubMed ID: 22715552
[No Abstract] [Full Text] [Related]
14. Sun-downing and integration for the advancement of science and therapeutics: the National Institute on Substance Use Disorders (NISUD).
Grabowski J
Addiction; 2010 Dec; 105(12):2044-9. PubMed ID: 20712817
[TBL] [Abstract][Full Text] [Related]
15. Little science, big science: strategies for research portfolio selection in academic surgery departments.
Shah A; Pietrobon R; Cook C; Sheth NP; Nguyen L; Guo L; Jacobs DO; Kuo PC
Ann Surg; 2007 Dec; 246(6):1110-5. PubMed ID: 18043118
[TBL] [Abstract][Full Text] [Related]
16. Brown and Tufts scientists among those to receive NIH funding for AIDS research.
D'Auria J
J Investig Med; 1998 Dec; 46(9):421. PubMed ID: 9861776
[No Abstract] [Full Text] [Related]
17. The role of inter-alpha inhibitor proteins in the diagnosis of neonatal sepsis.
Chaaban H; Singh K; Huang J; Siryaporn E; Lim YP; Padbury JF
J Pediatr; 2009 Apr; 154(4):620-622.e1. PubMed ID: 19324226
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal studies of inter-alpha inhibitor proteins in severely septic patients: a potential clinical marker and mediator of severe sepsis.
Opal SM; Lim YP; Siryaporn E; Moldawer LL; Pribble JP; Palardy JE; Souza S
Crit Care Med; 2007 Feb; 35(2):387-92. PubMed ID: 17205024
[TBL] [Abstract][Full Text] [Related]
19. Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A cross-sectional study.
Lamarre-Cliche M; Castilloux AM; LeLorier J
Clin Invest Med; 2001 Apr; 24(2):83-9. PubMed ID: 11368150
[TBL] [Abstract][Full Text] [Related]
20. Summary of NIH Medical-Surgical Emergency Research Roundtable held on April 30 to May 1, 2009.
Kaji AH; Lewis RJ; Beavers-May T; Berg R; Bulger E; Cairns C; Callaway C; Camargo CA; Carcillo J; DeBiasi R; Diaz T; Ducharme F; Glickman S; Heilpern K; Hickey R; Hoek TV; Hollander J; Janson S; Jurkovich G; Kellermann A; Kingsmore S; Kline J; Kuppermann N; Lowe R; McLario D; Nathanson L; Nichol G; Peitzman A; Richardson L; Sanders A; Shah M; Shapiro N; Silverman R; Than M; Wilber S; Yealy DM;
Ann Emerg Med; 2010 Nov; 56(5):522-37. PubMed ID: 21036293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
